相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis
Aleksandra Kaluzna et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Jason P. Lynch et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
Intestinal anti-inflammatory effects of probiotics in DNBS-colitis via modulation of gut microbiota and microRNAs
Francesca Algieri et al.
EUROPEAN JOURNAL OF NUTRITION (2021)
Biomaterials coating for on-demand bacteria delivery: Selective release, adhesion, and detachment
Jun Liu et al.
NANO TODAY (2021)
Metabolic engineering of probiotic Escherichia coli for cytolytic therapy of tumors
Chung-Jen Chiang et al.
SCIENTIFIC REPORTS (2021)
Metabolomics-Guided Hypothesis Generation for Mechanisms of Intestinal Protection by Live Biotherapeutic Products
Jiayu Ye et al.
BIOMOLECULES (2021)
Improved digestive stability of probiotics encapsulated within poly(vinyl alcohol)/cellulose acetate hybrid fibers
Emine Merve Canga et al.
CARBOHYDRATE POLYMERS (2021)
Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis
Xu Yan et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
NIR light-responsive bacteria with live bio-glue coatings for precise colonization in the gut
Meihui Cui et al.
CELL REPORTS (2021)
Probiotics, Prebiotics and Synbiotics in Inflammatory Bowel Diseases
Katarzyna Akutko et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Evaluation of E. coli Nissle1917 derived metabolites in modulating key mediator genes of the TLR signaling pathway
Sheyda Damoogh et al.
BMC RESEARCH NOTES (2021)
Genetically Engineered Escherichia coli Nissle 1917 Secreting GLP-1 Analog Exhibits Potential Antiobesity Effect in High-Fat Diet-Induced Obesity Mice
Jie Ma et al.
OBESITY (2020)
Bioengineered Escherichia coli Nissle 1917 for tumour-targeting therapy
Xiaoli Yu et al.
MICROBIAL BIOTECHNOLOGY (2020)
Encapsulation of Escherichia coli strain Nissle 1917 in a chitosan-alginate matrix by combining layer-by-layer assembly with CaCl2 cross-linking for an effective treatment of inflammatory bowel diseases
Xiaoming Luo et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Surface Modifications for Improved Delivery and Function of Therapeutic Bacteria
Ava M. Vargason et al.
SMALL (2020)
Beneficial effects resulting from oral administration of Escherichia coli Nissle 1917 on a chronic colitis model
E. L. S. Souza et al.
BENEFICIAL MICROBES (2020)
A designed whole-cell biosensor for live diagnosis of gut inflammation through nitrate sensing
Seung-Gyun Woo et al.
BIOSENSORS & BIOELECTRONICS (2020)
Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases
Hao Li et al.
FOOD & FUNCTION (2020)
Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases
Konrad Aden et al.
GASTROENTEROLOGY (2019)
Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease - An Overview of Human Studies
Paulo Jose Basso et al.
FRONTIERS IN PHARMACOLOGY (2019)
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
Pichet Praveschotinunt et al.
NATURE COMMUNICATIONS (2019)
Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment
Zhenping Cao et al.
NATURE COMMUNICATIONS (2019)
Nononcogenic restoration of the intestinal barrier by E. coli-delivered human EGF
Mira Yu et al.
JCI INSIGHT (2019)
Toll-like Receptors and inflammatory Bowel Disease
Yue Lu et al.
FRONTIERS IN IMMUNOLOGY (2018)
The probiotic strain Escherichia coli Nissle 1917 prevents papain-induced respiratory barrier injury and severe allergic inflammation in mice
Thomas Secher et al.
SCIENTIFIC REPORTS (2018)
E-coli Nissle microencapsulation in alginate-chitosan nanoparticles and its effect on Campylobacter jejuni in vitro
Asmaa Mawad et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
rSj16 Protects against DSS-Induced Colitis by Inhibiting the PPAR-α Signaling Pathway
Lifu Wang et al.
THERANOSTICS (2017)
Intestinal Anti-inflammatory Effects of Outer Membrane Vesicles from Escherichia coli Nissle 1917 in DSS-Experimental Colitis in Mice
Maria-Jose Fabrega et al.
FRONTIERS IN MICROBIOLOGY (2017)
Gut biogeography of the bacterial microbiota
Gregory P. Donaldson et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Microcins mediate competition among Enterobacteriaceae in the inflamed gut
Martina Sassone-Corsi et al.
NATURE (2016)
Outer Membrane Vesicles from the Probiotic Escherichia coli Nissle 1917 and the Commensal ECOR12 Enter Intestinal Epithelial Cells via Clathrin-Dependent Endocytosis and Elicit Differential Effects on DNA Damage
Maria-Alexandra Canas et al.
PLOS ONE (2016)
Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties
Ulrich Sonnenborn
FEMS MICROBIOLOGY LETTERS (2016)
Role of type 2 immunity in intestinal inflammation
Giorgos Bamias et al.
CURRENT OPINION IN GASTROENTEROLOGY (2015)
The Genotoxin Colibactin Is a Determinant of Virulence in Escherichia coli K1 Experimental Neonatal Systemic Infection
Alex J. McCarthy et al.
INFECTION AND IMMUNITY (2015)
Anti-inflammatory effects of Crataeva nurvala Buch. Ham. are mediated via inactivation of ERK but not NF-kappa B
Young-Chang Cho et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
Escherichia coli Nissle 1917 in ulcerative colitis treatment: systematic review and meta-analysis
Journal of Gastrointestinal and Liver Diseases (2015)
A pH-responsive supramolecular polymer gel as an enteric elastomer for use in gastric devices
Shiyi Zhang et al.
NATURE MATERIALS (2015)
Role of F1C Fimbriae, Flagella, and Secreted Bacterial Components in the Inhibitory Effect of Probiotic Escherichia coli Nissle 1917 on Atypical Enteropathogenic E-coli Infection
Sylvia Kleta et al.
INFECTION AND IMMUNITY (2014)
A Laminated Polymer Film Formulation for Enteric Delivery of Live Vaccine and Probiotic Bacteria
Joao M. S. de Barros et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
A Transgenic Probiotic Secreting a Parasite Immunomodulator for Site-Directed Treatment of Gut Inflammation
Rose A. Whelan et al.
MOLECULAR THERAPY (2014)
TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCζ and ERK1/2 signaling in HT-29/B6 cells
N. A. Hering et al.
MUCOSAL IMMUNOLOGY (2014)
Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics
Julio Plaza-Diaz et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Advances in understanding of bile acid diarrhea
Michael Camilleri
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Probiotic Bacteria Reduce Salmonella Typhimurium Intestinal Colonization by Competing for Iron
Elisa Deriu et al.
CELL HOST & MICROBE (2013)
Control of pathogens and pathobionts by the gut microbiota
Nobuhiko Kamada et al.
NATURE IMMUNOLOGY (2013)
The long term oral regulation of blood glucose in diabetic patients by using of Escherichia coli Nissle 1917 expressing CTB-IGF-1 hybrid protein
Zahra Bazi et al.
MEDICAL HYPOTHESES (2013)
Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut
Sebastian E. Winter et al.
SCIENCE (2013)
Enhanced Wound Healing by Recombinant Escherichia coli Nissle 1917 via Human Epidermal Growth Factor Receptor in Human Intestinal Epithelial Cells: Therapeutic Implication Using Recombinant Probiotics
Hye Jin Choi et al.
INFECTION AND IMMUNITY (2012)
Anti-inflammatory modulation of immune response by probiotic Escherichia coli Nissle 1917 in human blood mononuclear cells
Anne-Katrin Guettsches et al.
INNATE IMMUNITY (2012)
Identification of specific miRNAs targeting proteins of the apical junctional complex that simulate the probiotic effect of E. coli Nissle 1917 on T84 epithelial cells
Katharina Veltman et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice
Natividad Garrido-Mesa et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Probiotic factors partially improve parameters of 5-fluorouracil-induced intestinal mucositis in rats
Luca D. Prisciandaro et al.
CANCER BIOLOGY & THERAPY (2011)
Interference of Bifidobacterium choerinum or Escherichia coli Nissle 1917 with Salmonella Typhimurium in gnotobiotic piglets correlates with cytokine patterns in blood and intestine
A. Splichalova et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Morphometric analysis of the porcine gastrointestinal tract in a 10-day high-dose indomethacin administration with or without probiotic bacteria Escherichia coli Nissle 1917
J. Bures et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2011)
1075 The Nonribosomal Peptide-Polyketide Colibactin is Responsible for the Colonic Anti-Inflammatory Properties of the Probiotic Strain E. coli Nissle 1917
Maïwenn Olier et al.
GASTROENTEROLOGY (2010)
The K5 Capsule of Escherichia coli Strain Nissle 1917 Is Important in Stimulating Expression of Toll-Like Receptor 5, CD14, MyD88, and TRIF Together with the Induction of Interleukin-8 Expression via the Mitogen-Activated Protein Kinase Pathway in Epithelial Cells
Mohamed Hafez et al.
INFECTION AND IMMUNITY (2010)
Safety of Probiotic Escherichia coli Strain Nissle 1917 Depends on Intestinal Microbiota and Adaptive Immunity of the Host
Kerstin Gronbach et al.
INFECTION AND IMMUNITY (2010)
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
K. Vandenbroucke et al.
MUCOSAL IMMUNOLOGY (2010)
Physiological and pathological roles for microRNAs in the immune system
Ryan M. O'Connell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Zonula Occludens-1 and-2 Are Cytosolic Scaffolds That Regulate the Assembly of Cellular Junctions
Alan S. Fanning et al.
MOLECULAR STRUCTURE AND FUNCTION OF THE TIGHT JUNCTION: FROM BASIC MECHANISMS TO CLINICAL MANIFESTATIONS (2009)
Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli
Rolf Reissbrodt et al.
FEMS MICROBIOLOGY LETTERS (2009)
Clinical use of E-coli Nissle 1917 in inflammatory bowel disease
Michael Schultz
INFLAMMATORY BOWEL DISEASES (2008)
Helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-Producing macrophages
Corinna Schnoeller et al.
JOURNAL OF IMMUNOLOGY (2008)
The Probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells
Alip Borthakur et al.
JOURNAL OF NUTRITION (2008)
Induction of human β-defensin 2 by the probiotic Escherichia coli nissle 1917 is mediated throuah flagellin
Miriam Schlee et al.
INFECTION AND IMMUNITY (2007)
The fundamental basis of inflammatory bowel disease
Warren Strober et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCζ redistribution resulting in tight junction and epithelial barrier repair
Agata A. Zyrek et al.
CELLULAR MICROBIOLOGY (2007)
Lactobacilli, bifidobacteria and E-coli nissle induce pro- an anti-inflammatory cytokines in peripheral blood mononuclear cells
Ulf Helwig et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Toward a live microbial microbicide for HIV: Commensal bacteria secreting an HIV fusion inhibitor peptide
S Rao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Review article: practical management of inflammatory bowel disease patients taking immunomodulators
CA Siegel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Intestinal immunity of Escherichia coli NISSLE 1917:: a safe carrier for therapeutic molecules
AM Westendorf et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2005)
Escherichia coli Nissle 1917 distinctively modulates T-cell cycling and expansion via toll-like receptor 2 signaling
A Sturm et al.
INFECTION AND IMMUNITY (2005)
Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917
L Grozdanov et al.
JOURNAL OF BACTERIOLOGY (2004)
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
W Kruis et al.
GUT (2004)
NF-κB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917:: A novel effect of a probiotic bacterium
J Wehkamp et al.
INFECTION AND IMMUNITY (2004)
Trefoil factors: Initiators of mucosal healing
D Taupin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917
L Grozdanov et al.
JOURNAL OF BACTERIOLOGY (2002)
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
K Madsen et al.
GASTROENTEROLOGY (2001)
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
L Steidler et al.
SCIENCE (2000)
分享论文
